|
DE2617646C2
(de)
*
|
1976-04-22 |
1986-07-31 |
Hoechst Ag, 6230 Frankfurt |
Nonapeptid-amide und Decapeptid-amide mit Gonadoliberin-Wirkung, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
|
|
GB1524747A
(en)
*
|
1976-05-11 |
1978-09-13 |
Ici Ltd |
Polypeptide
|
|
DE2735515A1
(de)
*
|
1977-08-06 |
1979-02-22 |
Hoechst Ag |
Verwendung von lh-rh-peptiden als antikonzeptive
|
|
FR2450109B1
(fr)
*
|
1977-11-08 |
1986-03-28 |
Roussel Uclaf |
Nouvelle methode de traitement utilisant la lh-rh, ou des agonistes
|
|
IT1149971B
(it)
*
|
1979-06-11 |
1986-12-10 |
Syntex Inc |
Derivati nonapeptide e decapeptide dell'ormone che rilascia l'ormone luteinizzante
|
|
US4234571A
(en)
*
|
1979-06-11 |
1980-11-18 |
Syntex (U.S.A.) Inc. |
Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone
|
|
DE3020941A1
(de)
*
|
1980-06-03 |
1981-12-17 |
Hoechst Ag, 6000 Frankfurt |
Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung
|
|
HU185535B
(en)
*
|
1982-05-25 |
1985-02-28 |
Mta Koezponti Hivatala |
Process for preparing new gonadoliberin derivatives
|
|
AT390066B
(de)
*
|
1983-03-29 |
1990-03-12 |
Richter Gedeon Vegyeszet |
Verfahren zur herstellung von neuen gonadoliberin-derivaten
|
|
HU187503B
(en)
*
|
1983-03-29 |
1986-01-28 |
Magyar Tudomanyos Akademia,Hu |
Process for preparing gonadoliberine derivatives containing beta-aspartyl group
|
|
DE3411224A1
(de)
*
|
1984-03-27 |
1985-10-10 |
Hoechst Ag, 6230 Frankfurt |
Verfahren zur racematarmen herstellung von peptidzwischenprodukten der gonadorelin- und gonadorelinanaloga-synthese und neue zwischenprodukte bei diesem verfahren
|
|
US4760053A
(en)
*
|
1984-08-02 |
1988-07-26 |
Fernand Labrie |
Combination therapy for selected sex steroid dependent cancers
|
|
US4775660A
(en)
*
|
1984-08-02 |
1988-10-04 |
Fernand Labrie |
Treatment of breast cancer by combination therapy
|
|
US4666885A
(en)
*
|
1985-02-08 |
1987-05-19 |
Fernand Labrie |
Combination therapy for treatment of female breast cancer
|
|
HU193093B
(en)
*
|
1985-04-16 |
1987-08-28 |
Innofinance |
Process for stimulating sexual activity of birds and domestic mammalians and process for producing spermatocytes for their propagation
|
|
HU194280B
(en)
*
|
1985-10-22 |
1988-01-28 |
Richter Gedeon Vegyeszet |
Process for producing new gonadoliberin analogues of high effectivity and pharmaceutical compositions containing them
|
|
NZ244499A
(en)
*
|
1989-03-10 |
1999-05-28 |
Endorecherche Inc |
Treating breast or endometrial cancer with antiestrogen plus one of an androgen, a progestin and an inhibitor of sex steroid formation or secretion of prolactin, growth hormone or acth
|
|
US5372996A
(en)
*
|
1989-03-10 |
1994-12-13 |
Endorecherche, Inc. |
Method of treatment of androgen-related diseases
|
|
JPH0235232A
(ja)
*
|
1989-06-29 |
1990-02-05 |
Nhk Spring Co Ltd |
気室と液室を有する圧力容器
|
|
JP2959839B2
(ja)
*
|
1989-07-07 |
1999-10-06 |
アンドルシェルシュ・インコーポレイテッド |
性ステロイド活性の抑制における使用のためのアンドロゲン誘導体
|
|
EP0595796B1
(en)
*
|
1989-07-07 |
2003-01-15 |
Endorecherche Inc. |
Method of treatment of androgen-related diseases
|
|
CA2029018A1
(en)
*
|
1989-11-01 |
1991-05-02 |
Robert P. Millar |
Analogues of gonadotropin releasing hormone
|
|
JPH0474770U
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
*
|
1990-10-31 |
1992-06-30 |
|
|
|
FI945457A7
(fi)
*
|
1992-05-21 |
1995-01-16 |
Endorecherche Inc |
Testosteronin 5alfa-reduktaasiaktiviteetin inhibiittorit
|
|
US6413536B1
(en)
|
1995-06-07 |
2002-07-02 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
US7833543B2
(en)
*
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
CA2192782C
(en)
|
1995-12-15 |
2008-10-14 |
Nobuyuki Takechi |
Production of microspheres
|
|
CA2192773C
(en)
|
1995-12-15 |
2008-09-23 |
Hiroaki Okada |
Production of sustained-release preparation for injection
|
|
US20060025328A1
(en)
*
|
1997-05-28 |
2006-02-02 |
Burns Patrick J |
Compositions suitable for controlled release of the hormone GnRH and its analogs
|
|
US6051558A
(en)
*
|
1997-05-28 |
2000-04-18 |
Southern Biosystems, Inc. |
Compositions suitable for controlled release of the hormone GnRH and its analogs
|
|
US6242421B1
(en)
|
1997-11-06 |
2001-06-05 |
Richard Lloyd Bowen |
Methods for preventing and treating Alzheimer's disease
|
|
ES2154590B1
(es)
|
1999-05-20 |
2001-11-01 |
Lipotec Sa |
Procedimiento de sintesis de peptidos en fase solida
|
|
AR023940A1
(es)
|
2000-05-03 |
2002-09-04 |
Eriochem Sa |
Procedimiento para la produccion de microcapsulas de liberacion prolongada de peptidos solubles en agua
|
|
JP2004535431A
(ja)
|
2001-06-22 |
2004-11-25 |
サザン バイオシステムズ， インコーポレイテッド |
ゼロ次長期放出同軸インプラント
|
|
US20060287282A1
(en)
*
|
2001-06-25 |
2006-12-21 |
Steiner Mitchell S |
Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof
|
|
WO2003015820A1
(fr)
*
|
2001-08-10 |
2003-02-27 |
Takeda Chemical Industries, Ltd. |
Medicaments combines d'agoniste de la gnrh
|
|
WO2003041739A1
(en)
|
2001-11-13 |
2003-05-22 |
Takeda Chemical Industries, Ltd. |
Anticaner agents
|
|
US20030144203A1
(en)
*
|
2001-12-19 |
2003-07-31 |
Voyager Pharmaceutical Corporation |
Methods for slowing senescence and treating and preventing diseases associated with senescence
|
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
|
CN1774241B
(zh)
*
|
2002-12-13 |
2010-05-05 |
杜雷科特公司 |
包含高粘度液体载体材料的口服递药系统
|
|
GB0307777D0
(en)
*
|
2003-04-04 |
2003-05-07 |
Medical Res Council |
Conjugate compounds
|
|
MX2007002962A
(es)
|
2004-09-17 |
2008-03-05 |
Durect Corp |
Sistema de distribucion controlada.
|
|
ES2552338T3
(es)
|
2005-01-21 |
2015-11-27 |
Astex Therapeutics Limited |
Compuestos farmacéuticos
|
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
US7942867B2
(en)
*
|
2005-11-09 |
2011-05-17 |
The Invention Science Fund I, Llc |
Remotely controlled substance delivery device
|
|
WO2008044041A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
JP5528807B2
(ja)
|
2006-10-12 |
2014-06-25 |
アステックス、セラピューティックス、リミテッド |
複合薬剤
|
|
PT2117521E
(pt)
|
2006-11-03 |
2012-09-10 |
Durect Corp |
Sistemas de administração transdérmica que compreendem bupivacaína
|
|
EP2067471B1
(en)
*
|
2007-12-06 |
2018-02-14 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
|
RU2444525C2
(ru)
*
|
2010-06-09 |
2012-03-10 |
Закрытое Акционерное Общество "Фарм-Синтез" |
Способ получения нонапептидэтиламида и промежуточные соединения для его получения
|
|
KR20190042762A
(ko)
|
2010-06-16 |
2019-04-24 |
앙도르쉐르슈 인코포레이티드 |
에스트로겐-관련 질병의 치료 또는 예방 방법
|
|
AU2014233453A1
(en)
|
2013-03-15 |
2015-10-01 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
|
CA3028450A1
(en)
|
2016-07-06 |
2018-01-11 |
Durect Corporation |
Oral dosage form with drug composition, barrier layer and drug layer
|
|
WO2021146215A1
(en)
|
2020-01-13 |
2021-07-22 |
Durect Corporation |
Sustained release drug delivery systems with reduced impurities and related methods
|